Neuraminidase inhibitors and their role in avian and pandemic influenzaCRUSAT, Martin; DE JONG, Menno D.Antiviral therapy (London). 2007, Vol 12, Num 4, pp 593-602, issn 1359-6535, 10 p., bArticle

Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivoALYMOVA, Irina V; TAYLOR, Garry; TAKIMOTO, Toru et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 5, pp 1495-1502, issn 0066-4804, 8 p.Article

Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitorsMISHIN, Vasiliy P; HAYDEN, Frederick G; GUBAREVA, Larisa V et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 11, pp 4515-4520, issn 0066-4804, 6 p.Article

Neuraminidase Inhibitor Susceptibility Network position statement : antiviral resistance in influenza A/H5N1 virusesHAYDEN, Frederick; KLIMOV, Alexander; ZAMBON, Maria et al.Antiviral therapy (London). 2005, Vol 10, Num 8, pp 873-877, issn 1359-6535, 5 p.Article

Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cellsGOVORKOVA, Elena A; FANG, Hong-Bin; MING TAN et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 12, pp 4855-4863, issn 0066-4804, 9 p.Article

Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibilityYEN, Hui-Ling; HERLOCHER, Louise M; HOFFMANN, Erich et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 10, pp 4075-4084, issn 0066-4804, 10 p.Article

In vitro generation and characterisation of an influenza B variant with reduced sensitivity to neuraminidase inhibitorsAI LEE CHEAM; BARR, Ian G; HAMPSON, Alan W et al.Antiviral research. 2004, Vol 63, Num 3, pp 177-181, issn 0166-3542, 5 p.Article

Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitorsHATAKEYAMA, Shuji; SUGAYA, Norio; MITAMURA, Keiko et al.JAMA, the journal of the American Medical Association. 2007, Vol 297, Num 13, pp 1435-1442, issn 0098-7484, 8 p.Article

Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza : randomized, controlled trials for prophylaxis and treatmentBARROSO, Luis; TREANOR, John; GUBAREVA, Larisa et al.Antiviral therapy (London). 2005, Vol 10, Num 8, pp 901-910, issn 1359-6535, 10 p.Article

Zanamivir : troubles neuropsychiatriques = Zanamivir and neuropsychiatric disordersLa Revue Prescrire. 2007, Vol 27, Num 287, issn 0247-7750, 670Article

Preparing for pandemic influenza : Should hospitals stockpile oseltamivir?CINTI, Sandro; CHENOWETH, Carol; MONTO, Arnold S et al.Infection control and hospital epidemiology. 2005, Vol 26, Num 11, pp 852-854, issn 0899-823X, 3 p.Article

The threat of avian influenza H5N1 : 'do we have the tools for the job?'OXFORD, John; LAMBKIN-WILLIAMS, Robert; MANN, Alex et al.Antiviral chemistry & chemotherapy. 2007, Vol 18, Num 2, pp 71-74, issn 0956-3202, 4 p.Article

Pharmacokinetics of oseltamivir in young and very elderly subjectsABE, Masaichi; SMITH, James; URAE, Akinori et al.The Annals of pharmacotherapy. 2006, Vol 40, Num 10, pp 1724-1730, issn 1060-0280, 7 p.Article

Neuraminidase inhibitor resistance in influenza virusesREECE, Phillip Andrew.Journal of medical virology. 2007, Vol 79, Num 10, pp 1577-1586, issn 0146-6615, 10 p.Article

Rapid degradation of oseltamivir phosphate in clinical samples by plasma esterasesLINDEGARDH, Niklas; DAVIES, Geraint R; TRAN TINH HIEN et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 9, pp 3197-3199, issn 0066-4804, 3 p.Article

Oseltamivir (Tamiflu®) and its potential for use in the event of an influenza pandemicWARD, Penelope; SMALL, Ian; SMITH, James et al.Journal of antimicrobial chemotherapy (Print). 2005, Vol 55, pp 5-21, issn 0305-7453, 17 p., SUP1Article

The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniaeALYMOVA, Irina V; PORTNER, Allen; TAKIMOTO, Toru et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 1, pp 398-405, issn 0066-4804, 8 p.Article

Glycochimie et thérapeutique Les inhibiteurs de neuraminidase face au risque de grippe aviaire = Neuraminidase inhibitors and risk of H5N1 influenzaGRAS-MASSE, H; WILLAND, N.Annales pharmaceutiques françaises. 2007, Vol 65, Num 1, pp 50-57, issn 0003-4509, 8 p.Conference Paper

Avian influenza virus infections in humansWONG, Samson S. Y; YUEN, Kwok-Yung.Chest. 2006, Vol 129, Num 1, pp 156-168, issn 0012-3692, 13 p.Article

Cooperative anti-influenza activities of respiratory innate immune proteins and neuraminidase inhibitorWHITE, Mitchell R; CROUCH, Erika; VAN EIJK, Martin et al.American journal of physiology. Lung cellular and molecular physiology. 2005, Vol 32, Num 5, pp L831-L840, issn 1040-0605Article

Duration of isolation of children with influenza A treated with oseltamivirKANO, Kenichi; SUNAGAWA, Sachiko; SHIMURA, Naoto et al.European journal of pediatrics. 2007, Vol 166, Num 2, pp 185-186, issn 0340-6199, 2 p.Article

Oseltamivir resistance during treatment of influenza A (H5N1) infectionDE JONG, Menno D; TRAN TAN THANH; MALIK PEIRIS, J. S et al.The New England journal of medicine. 2005, Vol 353, Num 25, pp 2667-2672, issn 0028-4793, 6 p.Article

Antiviral effect of catechins in green tea on influenza virusSONG, Jae-Min; LEE, Kwang-Hee; SEONG, Baik-Lin et al.Antiviral research. 2005, Vol 68, Num 2, pp 66-74, issn 0166-3542, 9 p.Article

Oseltamivir : Troubles neuropsychiatriques (suite) = Oseltamivir and neuropsychiatric disordersLa Revue Prescrire. 2007, Vol 27, Num 284, pp 435-435, issn 0247-7750, 1 p.Article

Sensitivity of influenza viruses to zanamivir and oseltamivir : A study performed on viruses circulating in france prior to the introduction of neuraminidase inhibitors in clinical practiceFERRARIS, O; KESSLER, N; LINA, B et al.Antiviral research. 2005, Vol 68, Num 1, pp 43-48, issn 0166-3542, 6 p.Article